Is this covered?

As the free for all and chaos ensues regarding the Affordable Care Act and will he or won’t he support reform, little changes with regards to the Medical Industrial Complex. I recall an Attorney once reprimanding me for using that term and I laughed and said I can’t take credit for it but thanks. Lawyers dumber than Doctors.

When I read the headline I thought Angelina Jolie has changed her mind or one of the Real Housewives went too far this time. But no this was an accident. Alright then.

And no this is not the first time nor will it be the last.   Think the Criminal Justice system is a hot mess well this is the same industry that shares a lab space. Think about that and what it means when technicians can find you guilty or innocent and in turn destroy your life.  These people are not geniuses who are exempt from stupidity.

Think of all the great Scientists and other minds that are being assembled in the White House that will place your health and life at risk as they choose to believe their science.  That is akin to the statement “my truth” which means what exactly?

The real issue here is that we are sure that Doctors and Scientists are infallible and bad news they aren’t and neither is the Pope.  This comment says quite a bit about how people feel regarding Physicians. 

My collegue’s pregnant wife was told she had a 4-inch ovarian cyst and required surgery. They were Kaiser patients, so the second and third opinions came from within Kaiser. I said to my collegue that I was sorry for his wife and her severe pain, and now facing a surgery while pregnant. He said she had no pain. I was immediately alarmed. How can she have a huge cyst with no pain? He proceeded to tell me about the fancy, expensive schools where these three doctors had gotten their medical training. He said there was an ultrasound that showed the cyst. I said it could be the baby, not a cyst. They put the wife under, cut her open, and there was NO CYST. My collegue recounted their surprise after the surgery. I said, so you are telling me none of these doctors bothered to FEEL this supposed cyst that somehow caused no pain with their hands before cutting her? He said, “I guess not, but they ARE the best.” This couple didn’t even report these dangerous doctors to the medical board. I’m sure they and their fancy parchment are out there endangering people daily. I don’t care if they went to Stanford and Harvard. These guys are idiots

And when Angelina Jolie went all nuts, well further nuts, and wrote about her bizarre need to have a double Mastectomy and Hysterectomy I knew that it was going to be a gold mine for Surgeons – both Oncology and Plastic – as women would run amok getting tested. If you have never watched the Real Housewives of Orange County I suggest you do as I get all my mental health and cancer knowledge via these crazy bitches.  I miss the lunatic star fucker Terry Dubrow who never saw a boob he could not fix.  This is the great mind behind The Swan where debasing and degrading women is a sport in Hollywood just ask anyone!  

But as you can read below it doesn’t work out that well and whoops! I hope she met her deductible. 

Damaged for the rest of my life’: Woman says surgeons mistakenly removed her breasts and uterus

The Washington Post
By Lindsey Bever October 24 2017

Elisha Cooke-Moore had been told she had cancer-causing genes.

The 36-year-old mother said an obstetrician-gynecologist noted that the results of her genetic testing showed she had a 50 percent chance of getting breast cancer and up to an 80 percent chance of getting uterine cancer, so she underwent a recommended double mastectomy and hysterectomy to try to beat the odds.

But Cooke-Moore, 36, from Gold Beach, Ore., said that months after she had the surgeries, she learned that her medical team was wrong — the test results were negative. Now she is suing Curry County Health District and members of her medical team for $1.8 million.

“I am damaged for the rest of my life,” she told The Washington Post in a phone interview Tuesday afternoon, her voice cracking.

The lawsuit states that Cooke-Moore had a total hysterectomy in August 2016 and, not two months later, a prophylactic bilateral nipple-sparing mastectomy along with breast implants.

During an annual exam in 2015, Cooke-Moore received genetic testing to determine her risk of breast and other cancers. Cooke-Moore said she had expressed concerns to her doctor regarding a family history of cancer, so it was agreed she would be tested for a BRCA 1 and BRCA 2 gene mutation. Although the results were negative, her nurse practitioner misinterpreted them — and Cooke-Moore was told she had the MLH1 gene mutation and Lynch syndrome, according to the medical malpractice lawsuit.

The National Institutes of Health states that Lynch syndrome increases the risks of many types of cancer, particularly those in the colon and rectum, but also ovarian, uterine and other cancers.

Cooke-Moore said her nurse practitioner, who seemingly misread the results, referred her to specialists within the Curry Health Network — gynecologist William Fitts, who performed her hysterectomy and then recommended surgeon Jessica Carlson to handled her double mastectomy and reconstruction. But Cooke-Moore said neither of the doctors independently confirmed the results.

The lawsuit claims that Cooke-Moore’s medical team “continued to negligently rely upon the misinterpreted genetic testing results.”

Cooke-Moore said a doctor even wrote a letter to her children, who do not live with her, urging them to get tested for the mutation.

“I’m dumbfounded. We’re all dumbfounded,” said Cooke-Moore’s attorney, Christopher Cauble. “They all should have caught this.”

Cauble said that in addition to needless operations, his client’s replacement implants were placed during the double mastectomy surgery, prompting at least 10 corrective surgeries to manage complications.

Representatives for the Curry Health Network and an attorney for the hospital and Fitts did not respond to requests for comment. An attorney for Carlson said she could not comment on pending litigation.

Cooke-Moore said she discovered the mistake earlier this year while reading through her test results and noticed that it read “negative.”

“Devastated,” she said, remembering how she felt at the time. “I’m just not sure how you can mistake a negative for a positive.”

If she had it to do over, Cooke-Moore said that she would probably get a second opinion before she agreed to have the surgeries.

More and more, medical experts are encouraging second opinions — not out of distrust, but to ensure that the doctor and patient are making the best decisions.

“Every patient has a right to a second opinion,” Joseph Fins, chief of medical ethics at New York-Presbyterian and Weill Cornell Medicine, told Columnist Steven Petrow, “and it would worry me if a physician was opposed.”

Major hospital systems, including the Cleveland Clinic and Johns Hopkins, even have remote second-opinion services so that patients across the country can more easily seek peace of mind.

Petrow recently wrote an op-ed for The Post titled: “I heard what my doctor thinks; now I want a second opinion. How do I get one?” In it, he bullet-pointed how patients should handle second opinions:

•Don’t be talked out of seeking another opinion by your current doctor or anyone else; this is your decision.

•Be upfront but respectful with your doctor. You are partners in this, and having your doctor on your side makes it easier to transfer your medical records and coordinate care.

•Don’t shop for a specialist who will tell you what you want to hear. You need the unvarnished truth.

•Provide the second doctor with all relevant information in your medical record. Fins warns about the “discontinuity of care if all the facts don’t follow you.”

Cooke-Moore said she was too trusting.

“I trusted my community,” Cooke-Moore said, adding that she has since been diagnosed with PTSD. “I guess shame on me. Maybe I shouldn’t have, but I did.”

Grade C for Care

A couple of weeks ago I read about Stem Cell treatments that are doing more harm than good but as we have no regulation nor ability to actually ensure that half the shit the quack professional class are pedaling, we must make ultimately life saving or debilitating decisions on our own.

Then the past few days the New York Times did a series on immunotherapy treatments with regards to cancer and who knew that actually using the bodies own defense mechanisms were more beneficial that the toxic shit that western medicine loves to use to treat cancer. That said, the minute drug companies and other members of the medical industrial complex get on board you know the train trip is going to get way more expensive and take way longer than it should

Again, whatever you need, want and more importantly can afford then have at it. I want to say my skepticism about western medicine is in response to the abusive and negligent treatment by the abusive providers at Harborview Medical Center, but no it was way earlier than that. I think the first exposure to Quacks was the Doctor who broke a needle in my arm doing a blood draw, then we have the other quacks treating my Mother for her high blood pressure, the varying Dentists that have been unbelievably amazing or unbelievably incompetent;  the therapists and other assorted individuals I have seen over the years to try to reconcile my pain and anger over the years for whatever ailed me. Yes I have tried to actually understand and seek professional help of all kinds for varying injuries or ailments but over time the bad simply outweighed the good so my respect and more importantly trust of the medical industrial complex is slim to none.

And so I go out of my way to understand and validate that by finding information so that others don’t have to and in turn make educated and more importantly informed decisions about their care. And here is just another example.

Why ‘Useless’ Surgery Is Still Popular

Gina Kolata
THE NEW YORK TIMES
AUG. 3, 2016

Before a drug can be marketed, it has to go through rigorous testing to show it is safe and effective. Surgery, though, is different. The Food and Drug Administration does not regulate surgical procedures. So what happens when an operation is subjected to and fails the ultimate test — a clinical trial in which patients are randomly assigned to have it or not?

The expectation is that medical practice will change if an operation turns out not to help.

If only.

It looks as if the onus is on patients to ask what evidence, if any, shows that surgery is better than other options.

Take what happened with spinal fusion, an operation that welds together adjacent vertebrae to relieve back pain from worn-out discs. Unlike most operations, it actually was tested in four clinical trials. The conclusion: Surgery was no better than alternative nonsurgical treatments, like supervised exercise and therapy to help patients deal with their fear of back pain. In both groups, the pain usually diminished or went away.

The studies were completed by the early 2000s and should have been enough to greatly limit or stop the surgery, says Dr. Richard Deyo, professor of evidence-based medicine at the Oregon Health and Sciences University. But that did not happen, according to a recent report. Instead, spinal fusion rates increased — the clinical trials had little effect.

Spinal fusion rates continued to soar in the United States until 2012, shortly after Blue Cross of North Carolina said it would no longer pay and some other insurers followed suit.

“It may be that financial disincentives accomplished something that scientific evidence alone didn’t,” Dr. Deyo said.

Other operations continue to be reimbursed, despite clinical trials that cast doubt on their effectiveness.

In 2009, the prestigious New England Journal of Medicine published results of separate clinical trials on a popular back operation, vertebroplasty, comparing it to a sham procedure. They found that there was no benefit — pain relief was the same in both groups. Yet it and a similar operation, Kyphoplasty, in which doctors inject a sort of cement into the spine to shore it up, continue to be performed.

Dr. David Kallmes of the Mayo Clinic, an author of the vertebroplasty paper, said he thought doctors continued to do the operations because insurers pay and because doctors remember their own patients who seemed better afterward.

“When you read a study, you reflect on whether it is representative of your patient population,” Dr. Kallmes said. “It is easy to conclude that the answer is ‘no.’ The mean age in the study is different or ‘I do it differently.’”

“I think there is a placebo effect not only on patients but on doctors,” Dr. Kallmes adds. “The successful patient is burned into their memories and the not-so-successful patient is not. Doctors can have a selective memory that leads them to conclude that, ‘Darn it, it works pretty well.’”

The latest controversy — and the operation that arguably has been studied the most in randomized clinical trials — is surgery for a torn meniscus, a sliver of cartilage that acts as a shock absorber in the knee. It’s a condition that often afflicts middle-aged and older people, simply as a consequence of degeneration that can occur with age and often accompanying osteoarthritis. The result can be a painful, swollen knee. Sometimes the knee can feel as if it catches or locks. So why not do an operation to trim or repair the torn tissue?

About 400,000 middle-aged and older Americans a year have meniscus surgery. And here is where it gets interesting. Orthopedists wondered if the operation made sense because they realized there was not even a clear relationship between knee pain and meniscus tears. When they did M.R.I. scans on knees of middle-aged people, they often saw meniscus tears in people who had no pain. And those who said their knee hurt tended to have osteoarthritis, which could be the real reason for their pain.

Added to that complication, said Dr. Jeffrey N. Katz, a professor of medicine and orthopedic surgery at Harvard Medical School, is the fact that not everyone improves after the surgery. “It is not regarded as a slam-dunk,” he said. As a result, he said, many doctors have been genuinely uncertain about which is better — exercise and physical therapy or surgery. That, in fact, was what led Dr. Katz and his colleagues to conduct a clinical trial comparing surgery with physical therapy in middle-aged people with a torn meniscus and knee pain.

The result: The surgery offered little to most who had it. Other studies came to the same conclusion, and so did a meta-analysis published last year of nine clinical trials testing the surgery. Patients tended to report less pain — but patients reported less pain no matter what the treatment, even fake surgery.

Then came yet another study, published on July 20 in The British Medical Journal. It compared the operation to exercise in patients who did not have osteoarthritis but had knee pain and meniscus tears. Once again, the surgery offered no additional benefit.

An accompanying editorial came to a scathing conclusion: The surgery is “a highly questionable practice without supporting evidence of even moderate quality,” adding, “Good evidence has been widely ignored.”

So what should patients be told? Should they even be offered the surgery?

Patients should be told that physical therapy is a good first-line therapy for pain relief, Dr. Katz said, but that surgery also relieves pain. Pain relief can take longer with physical therapy, he says. With surgery, he said, patients have to recover from the operation but are likely to be back at work within two weeks.

“At the end of the day,” he said, “patients ought to choose.”

Of course, how they choose might depend on how the choice is presented.

Here’s how Dr. Gordon H. Guyatt, a professor of medicine and epidemiology at McMaster University in Hamilton, Ontario, who wrote the editorial in The British Medical Journal, would deal with the clinical trial data:

“I personally think the operation should not be mentioned,” he says, adding that in his opinion the studies indicate the pain relief after surgery is a placebo effect. But if a doctor says anything, Dr. Guyatt suggests saying this: “We have randomized clinical trials that produce the highest quality of evidence. They strongly suggest that the procedure is next to useless. If there is any benefit, it is very small and there are downsides, expense and potential complications.”

Hearing that, he says, “I cannot imagine that anybody would say, ‘Go ahead. I will go for it.’”

The Medical Files

I read this op ed in the NY Times and thought well the public love it but the medical care industry does not.

A Health Care Safety Net the Public Loves

By THE EDITORIAL BOARD
The New York Times
AUG. 3, 2015

Recent public surveys show that Americans strongly support Medicare and Medicaid, the twin pillars of the health care safety net, and that approval of the Affordable Care Act, President Obama’s health care reform law, is steadily rising. The popularity of these three government programs is a stiff warning to critics, mostly Republicans, who seek to radically change or demolish them.

Last month, the Kaiser Family Foundation reported that a majority of the public and the vast majority of beneficiaries support Medicare, the federal program for elderly and disabled Americans, and Medicaid, the federal-state program for the poor. Majorities of Democrats, independents and Republicans all favor keeping Medicare as it is rather than converting it, as many Republican politicians have urged, to a program in which each enrollee would be given a fixed dollar contribution to buy health insurance.

There are legitimate concerns that the financial condition of Medicare could deteriorate as the baby boomers age and as health care costs continue to rise faster than normal inflation. Polls analyzed by Harvard researchers in the New England Journal of Medicine in 2013 showed the public strongly in favor of reducing Medicare spending to improve the long-term financial outlook of the program, but strongly opposed if the cuts would be used to reduce the deficit or pay for tax cuts.

As for Medicaid, the Kaiser survey found that more than 60 percent of the public opposes converting it from an entitlement, in which the federal and state governments split the cost for everyone who qualifies, to a block grant, in which the federal government would provide a fixed amount of money. Under that approach, the states would be struggling to keep all costs within that amount, which might well require reducing benefits.

The Affordable Care Act is also gaining support. The latest Gallup poll, published in July, showed that Americans’ approval of the law rose to 47 percent, the highest level since 2012. (About 83 percent of Democrats supported the law compared with 14 percent of Republicans.) Other surveys in June and July have also shown a closely split verdict, which is an improvement over earlier polls showing greater public opposition.

The growing approval of the act is likely to get stronger as more people gain coverage and benefit from it. These voters need to throw their political weight behind candidates for Congress and the White House in 2016 who will work to improve the law, not repeal or weaken it.

As the move to consolidate the insurance providers down to three behemoths with the most recent merger of Cigna and Anthem the price of health care will not be getting cheaper and competition to find affordable policies less so. To the point that the Obama Administration has asked States to look into the price increases requested by the insurers due to the demands of those who signed up as mandated under the Affordable Care Act.

Obama Administration Urges States to Cut Health Insurers’ Requests for Big Rate Increases

By ROBERT PEAR
The New York Times
AUG. 3, 2015

WASHINGTON — Hoping to avoid another political uproar over the Affordable Care Act, the Obama administration is trying to persuade states to cut back big rate increases requested by many health insurance companies for 2016.

In calling for aggressive regulation of rates, federal officials are setting up a potential clash with insurers. Some carriers said they paid out more in claims than they collected in premiums last year, so they lost money on policies sold in the new public marketplaces. After finding that new customers were sicker than expected, some health plans have sought increases of 10 percent to 40 percent or more.

Administration officials have political and financial reasons for wanting to hold down premiums. Big rate increases could undermine public support for the health care law, provide ammunition to Republican critics of the measure and increase costs for some consumers and the federal government.

Kevin J. Counihan, the chief executive of the federal insurance marketplace, is urging states to consider a range of factors before making their decisions.

“Recent claims data show healthier consumers,” Mr. Counihan said in a letter to state insurance commissioners. The federal tax penalty for going without insurance will increase in 2016, he said, and this “should motivate a new segment of uninsured who may not have a high need for health care to enroll for coverage.”

In addition, federal officials said, much of the pent-up demand for health care has been met because consumers who enrolled last year have received treatments they could not obtain when they were uninsured.

Federal officials have also told state regulators that medical inflation will be less than what many insurers assumed in calculating their rates for 2016.

But Scott Keefer, a vice president of Blue Cross and Blue Shield of Minnesota, which requested rate increases averaging about 50 percent for 2016, said his company had not seen an improvement in the health status of new customers.

“Our claims experience has not slowed at all,” Mr. Keefer said. “The trend has gotten a little worse than we expected.”

Like other insurers, Blue Cross and Blue Shield of Minnesota reported a surge in prescription drug expenses. Two high-cost specialty drugs for rheumatoid arthritis, Enbrel and Humira, account for one-fourth of prescription drug costs in the company’s individual health plans, Mr. Keefer said. Other insurers reported high costs for hepatitis C medications.

State officials said their agencies had been reviewing insurance rates for decades and generally knew local market conditions better than federal officials.

Monica J. Lindeen, a Democrat who is the Montana insurance commissioner and the president of the National Association of Insurance Commissioners, said the letter from Mr. Counihan was interesting, but “did not point to any new information that would impact how state insurance departments regulate their health insurance markets.”

State officials said they had to worry about the solvency of some insurers as well as the affordability of insurance for consumers. In February, the Iowa insurance commissioner moved to shut down a nonprofit co-op insurer, and a state court found the company insolvent because of “adverse claims experience.” Another carrier, the Louisiana Health Cooperative, said it would voluntarily halt operations at the end of this year because it was “not growing enough.”

But administration officials said their arguments had already prevailed in several states, and President Obama, on a recent trip to Tennessee, said the final rates for 2016 would “come in significantly lower than what’s being requested.”

Moreover, consumers can avoid large rate increases by switching to lower-cost health plans next year, administration officials said. In any event, they said, the federal government pays most of the premium for most people who buy insurance on the exchanges, so consumers will be largely shielded from higher premiums.

California, one of the few states that actively negotiate prices, said health insurance rates would rise next year by an average of just 4 percent.

In New York, on average, insurers requested a 10.4 percent rate increase in the individual market, and state officials said they had reduced the average increase to 7.1 percent. “We closely analyzed each insurer’s request and cut rates that were excessive or unreasonable,” said Anthony J. Albanese, the acting superintendent of financial services in New York.

But the New York Health Plan Association, a trade group for insurers, criticized the state’s actions.

“The approved rates do not, in many cases, accurately reflect the financial status of plans as indicated in their rate submissions,” said Paul F. Macielak, president of the New York association. “Health plans have suffered financial losses the last two years when the state significantly reduced premium requests. Plans cannot be expected to continue losing money year after year and remain viable.”

The Affordable Care Act established a rate review process that requires insurers to disclose and justify large proposed increases. State officials have the primary responsibility for reviewing rates, except in five states that the Obama administration says do not have “effective rate review programs.”

In those states — Alabama, Missouri, Oklahoma, Texas and Wyoming — federal officials review rates. Several insurers said they had been flooded with questions from officials asking for more data on their claims experience and challenging their forecasts for 2016.

The federal government has urged states to hold public hearings on rate requests, and a consumer group in Missouri is urging the Obama administration to hold a hearing on increases requested by Coventry Health Care, a unit of Aetna. Coventry is seeking increases that average 19 percent in Missouri.

Rohan Hutchings, a spokesman for Aetna, said the proposed rates reflected the cost of care. “For 2016,” he said, “we expect that medical costs will grow by 8 percent to 10 percent in the individual market.” In addition, he said, the federal government is scaling back a transitional program that helps insurers pay certain very large claims.

Jay Angoff, a lawyer for the consumer group, the Consumers Council of Missouri, who is a former director of the state’s Insurance Department, said, “The federal government does not have authority to disapprove rates, but does have authority to deem them unreasonable,” and should do so. Coventry, he said, ignored the fact that “the least healthy people signed up first, in 2014, leaving a healthier group of people to sign up in 2016.”

And lastly the truth is medical care is a crapshoot. The cover of the Times today also had an article that many women with cervical cancer were not treated with an effecctive treatment program highly recommended from as far back as 2006 when the National Cancer Institute took the rare step of issuing a “clinical announcement.” A major study had just proved that pumping chemotherapy directly into the abdomen, along with the usual intravenous method, could add 16 months or more to women’s lives. Cancer experts agreed that medical practice should change — immediately. And nearly a decade later – crickets.

The article is here and what stood out was this:

Some may also see it as a drain on their income, because it is time-consuming and uses generic drugs on which oncologists make little money.

Dr. Markman said that when a treatment involves a new drug or a new device, manufacturers eagerly offer doctors advice and instructions on its use. But this treatment involves no new drugs or devices, so no one is clamoring to educate doctors about it. They are on their own to learn, and to train their nurses, a commitment that will take time and money.


This year, 21,290 new cases of ovarian cancer are expected in the United States, and 14,180 deaths. Dr. Markman said that for now, a patient’s best option is to ask whether her doctor offers the treatment, and if the answer is no, to find a doctor who does.

What about Susan G. Komen and their histrionics about Planned Parenthood a few years ago,  this would seem to be a better to way to channel energy as it is still cancer and cancer in women. But no. Walk on by.

The reality is that as the article concludes: But to bring about change, patients will have to speak up, she said, adding: “I think it’s going to have to be the advocate community, since they’re the ones who have the most skin in the game, and can put the money where the mouth is, and say, ‘If you can’t give me the best treatment I’ll go someplace else.’ ”

Being ill with a terminal illness facing the challenges that in and of itself alone is not enough, actually having to go out and find those willing to take you, take your insurance and in turn get the care you need to survive is something you will have to do on your own. Good luck with that.

Three Deadly Words

“You have cancer.” And apparently not. I was at the gym today and my normal treadmill reading (or Dentist office reading) is US People. The cover blurb on the story was surreal and further made me step on the step master. So I came home to research this Dr. “Death.”

Apparently this Dr. Death was recently sentenced to 50 years in Prison for fraud. He had was finally discovered after a whistleblower turned him in for his bullshit treatments of patients for cancer they did not have.

How Whistle-Blower Helped Expose Michigan Cancer Doctor Who Mistreated Patients
Jul 10, 2015,
By LAUREN EFFRON
ABC News»

Convicted Cancer Doctor Case Whistleblower, Victims Speak Out

An office manager for Dr. Farid Fata, the Michigan oncologist convicted of misdiagnosing hundreds of patients to defraud insurance companies, revealed details of how staffers helped expose the doctor’s crimes.

George Karadsheh, who worked for Dr. Farid Fata’s Crittenton Cancer Center in Rochester Hills, Michigan, said he started asking questions after staffers kept leaving the practice. When Karadsheh learned that a different oncologist in the practice was quitting, he said the doctor told him it was because Fata was administering chemotherapy to patients who didn’t need it.

“[This doctor] explained that Dr. Fata was actually administering chemotherapy to patients without need,” Karadsheh told ABC News “Nightline.” “He was also explaining that patients who were on hospice were taken off hospice and put on chemotherapy, put back on chemotherapy. He also pointed out that patients who were receiving chemotherapy without disease were receiving it to the very last day of life. So at that point I discovered that there may be some issues there.”

What is neglected in the this piece journalism vs the People version is that Dr. Fata had a staff member blow the whistle on him before for his bizarre practices early on and like all state run boards of quality assurance (here is WA state it is called MQAC or MQuack as its called) “investigated” and found nothing illegal or improper. I am guessing the investigation is calling the Doctor and going “are these allegations true?” and the Doctor emphatically going no.

Again much of this was to bilk Medicare. I am still waiting to hear of the scandalous gang of oldsters who have faked illnesses to get millions in free treatment. Well I did find this about 7 people who allegedly faked having cancer. They all had to pay restitution and serve some time. This Doctor however can be back in business in no time, no check the box for him apparently. Interesting that a Evangelical Minister and Doctor who did the same as that asshole, oh wait that term is for attorneys, this quack did to his “patients, was sentenced to a 150 years. Funny I thought they believed prayer can heal you. Maybe it was the whole tax fraud that did it.

There are dozens more articles and information about varying other Doctors who use junk science and pseudo science to misdiagnose and mistreat patients all int he name of money but they are largely ignored as was Dr. Death here in the beginning while opening up strip mall clinics to further fleece and abuse patients. God help us Tiny Tim.

The Association of Certified Fraud Examiners (yes there is a group that does this who knew) concludes that: Essentially, fraud in health care is just like in any other industry: Fraudsters with the means and opportunity take full advantage to unjustly profit. Health care crooks inside and outside the industry include patients, payers, employers, vendors and suppliers, and providers, including pharmacists. (Organized crime rings and computer hackers also play roles in committing health care fraud.)

The difference between the health care realm and many other industries is its huge, alluring, easy pile of cash. According to the Centers for Medicare & Medicaid Services (CMS), national health expenditures in the U.S. reached $2.6 trillion in 2010 — 17.9 percent of GDP. The CMS projects U.S. health spending to rise to 7.4 percent in 2014 as a result of the major coverage expansions from the U.S. Affordable Care Act (ACA) — an estimated 22 million people will be insured. Over the period of 2015-2021, health spending is projected to grow at an average rate of 6.2 percent annually.

And these are the most common:

TEN COMMON HEALTH CARE PROVIDER FRAUD SCHEMES

Billing for services not rendered.
Billing for a non-covered service as a covered service.
Misrepresenting dates of service.
Misrepresenting locations of service.
Misrepresenting provider of service.
Waiving of deductibles and/or co-payments.
Incorrect reporting of diagnoses or procedures (includes unbundling).
Overutilization of services.
Corruption (kickbacks and bribery).
False or unnecessary issuance of prescription drugs.

But there you go. A “legitimate” Doctor who had been turned in to the State medical board already by a whistleblower whom they ignored went on and damaged more lives gets 45 years in prison and could have been stopped sooner but hey let’s not question Doctors they are infallible, like the Pope and they too wear white.

Funny that it was People who did the most comprehensive story on this quack as I had not heard of it. This is just another example of how the medical industrial complex plays, dirty and dangerous. And at high costs in every sense of the word.

Money Maker

I am not sure who these Doctors are blaming – Obamacare, Big Pharma, Insurance companies, the Government as in Medicare/Medicaid, Patients or all of the above.  But what is clear is that Patient care is linked to Doctor’s compensation.  Less compensation means less care. Shocking, I know.

When the Doctors control the drugs, set the pricing this might explain why their is a lack of continuity with regards to pricing and in turn to care giving. More ways to show that income inequity is not just about work. It is about health care and once again the Affordable Care Act does nothing to prevent drug hoarding, price fixing or the increasing move to consolidate medical practices and in turn more ways to price jack.

Drug wars? Well they should add this to the list.

Private Oncologists Being Forced Out, leaving Patients to Face Higher Bills

GINA KOLATA
NOV. 23, 2014

When Dr. Jeffery Ward, a cancer specialist, and his partners sold their private practice to the Swedish Medical Center in Seattle, the hospital built them a new office suite 50 yards from the old place. The practice was bigger, but Dr. Ward saw the same patients and provided chemotherapy just like before. On the surface, nothing had changed but the setting

But there was one big difference. Treatments suddenly cost more, with higher co-payments for patients and higher bills for insurers. Because of quirks in the payment system, patients and their insurers pay hospitals and their doctors about twice what they pay independent oncologists for administering cancer treatments.

There also was a hidden difference — the money made from the drugs themselves. Cancer patients and their insurers buy chemotherapy drugs from their medical providers. Swedish Medical Center, like many other others, participates in a federal program that lets it purchase these drugs for about half what private practice doctors pay, greatly increasing profits

Oncologists like Dr. Ward say the reason they are being forced to sell or close their practices is because insurers have severely reduced payments to them and because the drugs they buy and sell to patients are now so expensive. Payments had gotten so low, Dr. Ward said, that they only way he and his partners could have stayed independent was to work for free. When he sold his practice, Dr. Ward said, “The hospital was a refuge, not the culprit

When a doctor is affiliated with a hospital, though, patients end up paying, out of pocket, an average $134 more per dose for the most commonly used cancer drugs, according to a report by IMS Health, a health care information company. And, the report notes, many cancer patients receive multiple drugs

“Say there was a Costco that had very good things at reasonable prices,” said Dr. Barry Brooks, a Dallas oncologist in private practice. “Then a Neiman Marcus comes in and changes the sign on the door and starts billing twice as much for the same things.” That, he said, is what is happening in oncology

A Quirk in Drug Pricing
Insurers pay hospitals and doctors affiliated with hospitals more to administer chemotherapy drugs than they pay independent doctors.

The situation is part of the unusual world of cancer medicine, where payment systems are unique and drive not just the price of care but what drugs patients may get and where they are treated. It raises questions about whether independent doctors, squeezed by finances, might be swayed to use drugs that give them greater profits or treat poorer patients differently than those who are better insured. But one thing is clear: The private practice oncologist is becoming a vanishing breed, driven away by the changing economics of cancer medicine.

Practices are making the move across the nation. Reporting on the nation’s 1,447 independent oncology practices, the Community Oncology Alliance, an advocacy group for independent practices, said that since 2008, 544 were purchased by or entered contractual relationships with hospitals, another 313 closed and 395 reported they were in tough financial straits. In western Washington, just one independent oncology group is left

Christian Downs, executive director of the Association of Community Cancer Centers, said that although there are no good data yet, he expected the Affordable Care Act was accelerating the trend. Many people bought inadequate insurance for the expensive cancer care they require. Community doctors have to buy the drugs ahead of time, placing a burden on them when patients cannot pay. The act also requires documentation of efficiencies in medical care which can be expensive for doctors in private practice to provide. And it encourages the consolidation of medical practices

The American Hospital Association cites advantages for patients being treated by hospital doctors.

“The hassle factor is reduced,” said Erik Rasmussen, the association’s vice president of legislative affairs. Patients can have scans, like CT and M.R.I., use a pharmacy and get lab tests all in one place instead of going from facility to facility, he said

And, he added, there is a reason hospitals get higher fees for their services — it compensates them for staying open 24 hours and caring for uninsured and underinsured patients

For doctors in private practice, providing chemotherapy to uninsured and Medicaid patients is a money loser. As a result, many, including Dr. Ward before he sold his practice, end up sending those patients to nearby hospitals for chemotherapy while keeping them as patients for office visits

“We hate doing it, I can’t tell you how much we hate doing it,” said Dr. Brooks, the Texas oncologist. “But I tell them, ‘It will cost me $200 to give you this medication in my office, so I am going to ask you to go to the hospital as an outpatient for infusions.’&nbsp

Dr. Peter Eisenberg, in private practice in Marin County in Northern California, said: “The disgrace is that we have to treat people differently depending on how much money they’ve got. That we do diminishes me

Society of Clinical Oncology. Many private practice oncology offices, he said, “Run on time, they are efficient, you get in, you get out, as opposed to academic medical centers where they may be an hour and a half behind

Dr. Ward and others in private practice said they tried for years to make a go of it but were finally defeated by what he described as “a series of cuts in oncology reimbursement under the guise of reform to which private practice is most vulnerable

Lower reimbursements have two effects. One is on overhead. Unlike other doctors, oncologists stock their own drugs, maintaining a sort of mini-pharmacy. If a patient gets too sick to receive a drug or dies, the doctor takes the loss. That used to be acceptable because insurers paid doctors at least twice the wholesale price of drugs. Now doctors are reimbursed for the average cost of the drug plus 4.3 percent, there are more and more drugs to stock, and drugs cost more

“The overhead is enormous,” Dr. Schilsky said. “This is one of the reasons why many oncologists are becoming hospital-based

The second — and bigger — effect is less profit from selling drugs to patients. For years, chemotherapy drugs provided a comfortable income. Those days are gone, doctors say

The finances are very different in hospitals, with their higher reimbursement rates for administering drugs, discounts for buying large quantities, and a special federal program that about 30 percent of hospitals qualify for. The program, to compensate research hospitals and hospitals serving poor people, lets hospitals buy chemotherapy drugs for all outpatients at about a 50 percent discount

In addition, Dr. Schilsky notes, cancer patients at hospitals use other services, like radiation therapy, imaging and surgery“A cancer patient is going to generate a lot of revenue for a hospital,” Dr. Schilsky said

Health care economists say they have little data on how the costs and profits from selling chemotherapy drugs are affecting patient care. Doctors are constantly reminded, though, of how much they can make if they buy more of a company’s drug

Celgene, for example, in a recent email about its drug Abraxane, told one doctor who had bought 50 vials that he could get a rebate of $647.51 by buying 68 vials. If he bought 175 vials he’d get $1,831.

This hidden profit possibility troubles Dr. Peter B. Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center

“When you walk into a doctor’s office you don’t know that in most cancer scenarios there are a range of therapeutic choices,” Dr. Bach said. “Unless the doctor presents options, you assume there aren’t any

While individual oncologists deny choosing treatments that provide them with the greatest profit, Dr. Kanti Rai, a cancer specialist at North Shore-Long Island Jewish Cancer Center, said it would be foolish to believe financial considerations never influence doctors’ choices of drugs

“Sometimes hidden in such choices — and many times not so hidden — are considerations of what also might be financially more profitable,” he said.